Ligand binding profiles of U-69,593-sensitive and -insensitive sites in human cerebral cortex membranes: Evidence of kappa opioid receptors heterogeneity

Life Sciences

Volumn 58, Issue 19, 1996, Pages 1671-1679

  Kim, Kee Won ^a   Eun, Young A ^a   Soh, Soo Mi ^b   Eun, Jae Soon ^b   Cho, Kyu Park ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Usok University   (South Korea)

Author keywords

diprenorphine; human cerebral cortex; opioid receptors heterogeneity; U69,593

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ALPHA NEOENDORPHIN; BETA ENDORPHIN; BREMAZOCINE; DIPRENORPHINE; DYNORPHIN A; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETHYLKETAZOCINE; HALOPERIDOL; KAPPA 1 OPIATE RECEPTOR AGONIST; KAPPA 2 OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; KAPPA1 OPIATE RECEPTOR; MORPHINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; QUADAZOCINE; RADIOLIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; BRAIN CORTEX; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EPILEPSY; FEMALE; HUMAN; HUMAN TISSUE; LIGAND BINDING; MALE;

EID: 0029967518     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00142-7     Document Type: Article

References (26)

1. M.J. MILLAN, Trends Pharmacol. Sci., 11 70-76 (1990)
2. A. PFEIFFER, A. PASI, P. MEHERAEIN, and A. HERZ, Neuropeptides 2 89-97 (1981)
3. P.F. von VOIGTLANDER, R.A. LAHTI, and J.H. LUDENS, J. Pharmacol. Exp. Ther. 224 7-12 (1983)
4. R.A. LAHTI, M.M. MICKERSON, J.M. McCALL, and P.F. von VOIGTLANDER, Eur. J. Pharmacol. 109 281-284 (1985)
5. R.S. ZUKIN, M. EGHBALI, D. OLIVE, E.M. UNTERWALD, and A. TEMPEL, Proc. Natl. Acad. Sci. USA 85 4061-4065 (1988)
6. M. TIBERI, and J. MAGNAN, Mol. Pharmacol. 37 694-703 (1990)
7. R.B. ROTHMAN, V. BYKOV, B.R. De COSTA, A.E. JACOBSON, K.C. RICE, and L.S. BRADY, Peptides 11 311-331 (1990)
8. B. NOCK, A.L. GIORDANO, T.J. CICERO, and L.H. O'CONNOR, J. Pharmacol. Exp. Ther. 254 412-429 (1990)
9. K.W. KIM, S.M. SO, S.C. PARK, and K.P. CHO, Regul. Pept. Supp. 1 S33-S34 (1994)
10. J.A. CLARK, L. LIU, M. PRICE, B. HERSH, M. EDELSON, and G.W. PASTERNAK, J. Pharmacol. Exp. Ther. 251 461-468 (1989)
11. A. PFEIFFER, A. PASI, P. MEHERAEIN, and A. HERZ, Brain Res. 248 87-96 (1982)
12. A.J. CROSS, C. HILLE, and P. SLATER, Neuroscience 20 65-107 (1987)
13. B.A. VOGT, M.D. PLAGER, P.B. CRINO, and E.D. Bird, Neuroscience 36 165-174 (1990)
14. K.L.R. JANSSEN, R.L.M. FAULL, M. DRAGUNOW, and R.A. LESLIE, Brain Res. 566 225-238 (1991)
15. R.B. ROTHMAN, V. BYKOV, B.G. XUE, H. XU, B.R. De COSTA, A.E. JACOBSON, K.C. RICE, J.E. KLEINMAN, and L.S. BRADY, Peptides 13 977-987 (1992)
16. R. QUIRION, C. PILAPIL, and J. MAGNAN, Cell. Mol. Neurobiol. 7 303-307 (1987)
17. P.J. MUNSON, and D. RODBARD, Anal. Biochem. 107 220-226 (1980)
18. O.H. LOWRY, N.J. ROSEBROUGH, L. FARR, and R.J. RANDALL, J. Biol. Chem. 193 265-273 (1951)
19. M.S. WOOD, and J.R. TRAYNOR, J. Neurochem. 53 173-178 (1989)
20. B. NOCK, A. RAJPARA, L. O'CONNOR, and T.J. CICERO, Life Sci. 42 2403-2412 (1988)
21. S. IYENGAR, H.S. KIM, and P.L. WOOD, Life Sci. 39 637-644 (1986)
22. K.W. KIM, and B.M. COX, J. Pharmacol. Exp. Ther. 267 1150-1156 (1993)
23. J. MAGNAN, and M. TIBERI, Develop. Brain Res. 45 275-282 (1989)
24. I.S. ZAGON, D.M. GIBO, and P.J. McLAUGHLIN, Brain Res. 523 62-68 (1990)
25. K.-J. CHANG, S.G. BLANCHARD, and P. CAUTRECASAS, Mol. Pharmacol. 26 484-488 (1984)
26. E.D. UNTERWALD, C. KNAPP, and R.S. ZUKIN, Brain Res. 562 57-65 (1991)